Welcure Drugs & Pharmaceuticals Ltd - 524661 - Intimation Under Regulation 30 - Rs. 517 Crore Global Sourcing Mandate

Welcure Drugs & Pharmaceuticals Ltd.

NSE: WELCURE | BSE: 524661 | ISIN: INE331C01017 | Industry: Pharmaceuticals
| Mid-range Performer

12.2500 0.58 (4.97%)

BSE Jul 16, 2025 09:50 AM

91.41% Gain from 52W Low

Volume: 786.2K

Welcure Drugs & Pharmaceuticals Ltd.

18 Jun 2025

12.25

4.97%

Company Update

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Intimation Under Regulation 30 - Rs. 517 Crore …

BSE India

Intimation under Regulation 30 - Rs. 517 Crores Global Sourcing Mandate

More from Welcure Drugs & Pharmaceuticals Ltd.

Recommended

Market opens flat, HDFC Life Insurance's Q1 net profit grows 14.5% YoY to Rs 548.4 crore

Trendlyne Marketwatch | 16 Jul 2025, 09:47AM

Five stocks to buy from analysts this week - July 15, 2025

The Baseline | 15 Jul 2025, 06:44PM

IPO spree continues with Anthem and two SME issues opening this week

| 14 Jul 2025, 04:42PM